Stop Smuggling Illicit Synthetic Drugs on U.S. Transportation Networks Act of 2024, Section 103. "Development of strategy to accelerate research and development of non-intrusive, advanced inspection technologies to detect illicit synthetic drugs"
Require the Director of the Office of Science and Technology Policy and the Director of the Office of National Drug Control Policy to develop a strategy for accelerating the research, development, and deployment of advanced inspection technologies, including AI and quantum computing, to detect illicit synthetic drugs. Mandate coordination with multiple agencies, including the National Science Foundation and the National Institute of Standards and Technology. Instruct submission of a report on the strategy to specified congressional committees within two years of the Act's enactment.
Paper
Full text
Stop Smuggling Illicit Synthetic Drugs on U.S. Transportation Networks Act of 2024, Section 103. "Development of strategy to accelerate research and development of non-intrusive, advanced inspection technologies to detect illicit synthetic drugs"
ETO AGORA · U.S. federal laws · 2024
Summary
Require the Director of the Office of Science and Technology Policy and the Director of the Office of National Drug Control Policy to develop a strategy for accelerating the research, development, and deployment of advanced inspection technologies, including AI and quantum computing, to detect illicit synthetic drugs.
Mandate coordination with multiple agencies, including the National Science Foundation and the National Institute of Standards and Technology.
Instruct submission of a report on the strategy to specified congressional committees within two years of the Act's enactment.
Defines "appropriate congressional committees" for strategy development on advanced drug detection technologies.
SEC. 103. Development of strategy to accelerate research and development of non-intrusive, advanced inspection technologies to detect illicit synthetic drugs. (a) Defined term.—In this section, the term “appropriate congressional committees” means—
(1) the Committee on Commerce, Science, and Transportation of the Senate;
(2) the Committee on Homeland Security and Governmental Affairs of the Senate;
(3) the Committee on Finance of the Senate;
(4) the Committee on the Judiciary of the Senate;
(5) the Committee on Energy and Commerce of the House of Representatives;
(6) the Committee on Homeland Security of the House of Representatives;
(7) the Committee on Financial Services of the House of Representatives; and
(8) the Committee on the Judiciary of the House of Representatives.
Develops a strategy for advanced drug detection technologies, and submits a report to Congress within two years.
(b) In general.—The Director of the Office of Science and Technology Policy and the Director of the Office of National Drug Control Policy, in consultation and coordination with the Director of the National Science Foundation, the Secretary of Commerce (acting through the Director of the National Institute of Standards and Technology), the Secretary of Energy, the Secretary of Homeland Security, the Administrator of the Transportation Security Administration, and the Attorney General, shall—
(1) develop a joint strategy to accelerate research and development and deployment of non-intrusive, advanced inspection technologies and other advanced inspection technologies to detect illicit synthetic drugs, such as artificial intelligence and quantum hybrid computing and integration of multiple data sources; and
(2) not later than 2 years after the date of the enactment of this Act, submit a report on such strategy to the appropriate congressional committees.